PURPOSE: The aim of the study was to investigate the ability of contrast-enhanced sonography (CEUS) with the contrast agent SonoVue to differentiate between benign and malignant focal liver lesions. METHODS: In a prospective study, we examined 317 patients (204 males, 113 females, aged 59 +/- 12 years) with focal liver lesions detected by B-mode gray-scale sonography. After intravenous injection of 1.2 mL SonoVue, the liver was examined continuously for 3 minutes using low-MI sonography with contrast-specific software. Final diagnosis was established by histopathology, CT, MRI, or HIDA-scintigraphy. RESULTS: Two hundred nine patients had malignant focal lesions, including 107 hepatocellular carcinomas, 70 metastases, 26 cholangiocellular carcinomas, and 6 other types of malignancy. One hundred eight patients had benign focal lesions, including 30 regenerative nodules, 30 hemangiomas, 13 cases of focal nodular hyperplasia, 12 abscesses, 8 cases of necrosis, 7 cases of focal steatosis areas, and 8 other benign lesions. Hypoenhancement or no enhancement in the late phase was found in 91% of the malignant lesions but in only 37% of the benign lesions (p < 0.001, sensitivity = 64%, specificity = 93%). Hyperenhancement in the late phase was found in 20% of the benign lesions but in none of the malignant lesions (p < 0.001, sensitivity = 21%, specificity = 100%). Hyperenhancement in the early phase with diffuse complete enhancement was found in 30% of the patients with malignant lesions but in only 2% of the patients with benign lesions (p < 0.001, sensitivity = 30%, specificity = 98%). CEUS had a sensitivity of 90%, a specificity of 99%, and an accuracy of 89% in the diagnosis of malignant liver lesions. CONCLUSION: CEUS is helpful in the differentiation between benign and malignant focal liver lesions. (c) 2009 Wiley Periodicals, Inc. J Clin Ultrasound, 2010.
PURPOSE: The aim of the study was to investigate the ability of contrast-enhanced sonography (CEUS) with the contrast agent SonoVue to differentiate between benign and malignant focal liver lesions. METHODS: In a prospective study, we examined 317 patients (204 males, 113 females, aged 59 +/- 12 years) with focal liver lesions detected by B-mode gray-scale sonography. After intravenous injection of 1.2 mL SonoVue, the liver was examined continuously for 3 minutes using low-MI sonography with contrast-specific software. Final diagnosis was established by histopathology, CT, MRI, or HIDA-scintigraphy. RESULTS: Two hundred nine patients had malignant focal lesions, including 107 hepatocellular carcinomas, 70 metastases, 26 cholangiocellular carcinomas, and 6 other types of malignancy. One hundred eight patients had benign focal lesions, including 30 regenerative nodules, 30 hemangiomas, 13 cases of focal nodular hyperplasia, 12 abscesses, 8 cases of necrosis, 7 cases of focal steatosis areas, and 8 other benign lesions. Hypoenhancement or no enhancement in the late phase was found in 91% of the malignant lesions but in only 37% of the benign lesions (p < 0.001, sensitivity = 64%, specificity = 93%). Hyperenhancement in the late phase was found in 20% of the benign lesions but in none of the malignant lesions (p < 0.001, sensitivity = 21%, specificity = 100%). Hyperenhancement in the early phase with diffuse complete enhancement was found in 30% of the patients with malignant lesions but in only 2% of the patients with benign lesions (p < 0.001, sensitivity = 30%, specificity = 98%). CEUS had a sensitivity of 90%, a specificity of 99%, and an accuracy of 89% in the diagnosis of malignant liver lesions. CONCLUSION: CEUS is helpful in the differentiation between benign and malignant focal liver lesions. (c) 2009 Wiley Periodicals, Inc. J Clin Ultrasound, 2010.
Authors: Inés Gómez Molins; Juan Manuel Fernández Font; Juan Carrero Alvaro; Jose Luís Lledó Navarro; Marta Fernández Gil; Conrado M Fernández Rodríguez Journal: World J Radiol Date: 2010-12-28
Authors: M Beth McCarville; Sue C Kaste; Fredric A Hoffer; Raja B Khan; R Christopher Walton; Bruce S Alpert; Wayne L Furman; Chenghong Li; Xiaoping Xiong Journal: Pediatr Radiol Date: 2012-01-17
Authors: Aneta D Petelska; Jacek R Janica; Joanna Kotynska; Urszula Łebkowska; Zbigniew A Figaszewski Journal: J Membr Biol Date: 2011-11-24 Impact factor: 1.843
Authors: Ilario de Sio; Maddalena D Iadevaia; Luigi M Vitale; Marco Niosi; Anna Del Prete; Chiara de Sio; Lorenzo Romano; Annalisa Funaro; Rosaria Meucci; Alessandro Federico; Carmelina Loguercio; Marco Romano Journal: United European Gastroenterol J Date: 2014-08 Impact factor: 4.623
Authors: Jaydev K Dave; Valgerdur G Halldorsdottir; John R Eisenbrey; Daniel A Merton; Ji-Bin Liu; Jian-Hua Zhou; Hsin-Kai Wang; Suhyun Park; Scott Dianis; Carl L Chalek; Feng Lin; Kai E Thomenius; Daniel B Brown; Flemming Forsberg Journal: Ultrasound Med Biol Date: 2012-08-21 Impact factor: 2.998
Authors: Casey N Ta; Yuko Kono; Mohammad Eghtedari; Young Taik Oh; Michelle L Robbin; Richard G Barr; Andrew C Kummel; Robert F Mattrey Journal: Radiology Date: 2017-10-25 Impact factor: 11.105